Our Pipeline of Experimental Therapies
Transforming Medicine. Redefining Healing. Building the Future of Regeneration
-
KH-1814
Exosome Therapy for Neurodegenerative Disorders
-
AVEXO
Acellular secretome therapy derived from clinical-grade amniotic fluid, enriched with exosomes and extracellular matrix proteins for Musculoskeletal Disorders
-
AIOVA
Combinatory stem cell therapy for complex injuries and degenerative conditions
-
NKIRA
A transformative NK-cell immunotherapy platform delivering durable, adaptable, and regenerative outcomes
-
GLP-1-AMX
Novel GLP-1 analog engineered to overcome the key limitations of current GLP-1 analogs
-
HydroKarma
Regenerative Aesthetics
Our Commitment
KweHealth’s pipeline reflects our mission to integrate advanced science, clinical innovation, and patient-centered design into therapies that push the boundaries of regenerative medicine.
All products featured here are experimental and under investigation in research and preclinical development. Our goal is to advance each program through rigorous clinical trials, regulatory pathways, and ultimately into therapies that change the way the world heals.